30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Anika Gains Australia Approval for MONOVISC Viscosupplement -

Anika Therapeutics received Australia regulatory approval to market MONOVISC® single-injection viscosupplement for the treatment of osteoarthritis pain in all synovial joints. MONOVISC is now available in 20+ counties, and ANIK plans to add more in 2018. Surgical Specialties will market MONOVISC throughout Australia and New Zealand per terms of a multi-year exclusive distribution agreement. (Anika Therapeutics, Inc., 10/16/17)